Browse the evidence

In patients with type 2 diabetes duration greater than 10 years, GLP-1RA plus basal insulin fixed-ratio combinations (iDegLira, iGlarLixi) may be numerically more effective for HbA1c reduction than tirzepatide, suggesting tirzepatide is better suited for early-stage disease.

For patients with type 2 diabetes for more than 10 years, GLP-1RA plus basal insulin fixed-ratio combinations may offer better glycemic control than tirzepatide alone, making them a strong option for long-standing disease.

Withholding GLP-1 receptor agonists for at least three half-lives before elective surgery is recommended for weight management patients to minimize retained gastric contents.

For weight loss patients: Check the half-life of your specific drug (e.g., Semaglutide ~7 days, Dulaglutide ~5 days). Stop taking it at least 3 times that duration before your scheduled surgery. For example, if you take Semaglutide (7-day half-life), stop at least 21 days before surgery. Consult your doctor for a bridge plan for blood sugar if applicable.

For patients with Type 2 Diabetes, prolonged cessation of GLP-1 receptor agonists may worsen peri-operative glycaemic control, requiring individualized management and endocrinologist consultation.

If you have Type 2 Diabetes, do not simply stop your GLP-1 drug without a plan. Stopping it can cause your blood sugar to rise dangerously high during surgery. You need a personalized plan from your doctor and likely an endocrinologist to manage your sugar levels during the period you are off the drug.

For adults with marginal or inadequate protein intake (<0.8 g/kg/day), consuming a more balanced protein distribution (spreading protein across meals) is superior to an unbalanced distribution for promoting skeletal muscle-related outcomes.

If you are currently eating less than 0.8 grams of protein per kilogram of body weight per day, try spreading your protein out more evenly across your meals. This helps your body use the protein it has more efficiently. However, if you are already eating a healthy amount of protein (0.8-1.3 g/kg), you don't need to stress about balancing every meal; just make sure at least one meal has enough protein (around 25-30g) to trigger muscle building.

For adults with adequate or high protein intake (0.8-1.3 g/kg/day), ensuring at least one meal contains sufficient protein to maximally stimulate muscle protein synthesis is sufficient for promoting skeletal muscle health, regardless of how the rest of the day's protein is distributed.

If you are already eating enough protein each day (around 0.8 to 1.3 grams per kilogram of body weight), you don't need to worry about spreading it out perfectly. Just make sure one meal a day has enough protein (about 25-30 grams) to trigger muscle building. The rest of your protein can be distributed however fits your schedule.

Long-term metformin therapy (up to 10 years) in overweight-obese women with PCOS and normal baseline glucose homeostasis results in significant initial weight loss, stabilization of body mass, improved menstrual frequency, and reduced androgen levels, with a very low conversion rate to diabetes.

For overweight or obese women with PCOS who have normal blood sugar, metformin (up to 2000mg/day) can help with weight loss, menstrual regularity, and lowering male hormones. The biggest weight loss happens in the first year, after which weight stabilizes. It is generally well-tolerated, but sticking with it long-term is hard because the initial excitement fades. Consistent use helps maintain these benefits and prevents diabetes.

Implementing national produce prescription programs for US adults with diabetes and food insecurity prevents cardiovascular disease events and generates quality-adjusted life years while being highly cost-effective.

For policymakers and healthcare systems, integrating produce prescriptions into care for diabetic, food-insecure patients is a financially sound investment that improves long-term health outcomes and reduces overall societal costs.

Specific genetic variants (e.g., FTO, TCF7L2, FABP2) modify the body's response to macronutrient intake, such that high-protein or specific fat/carbohydrate ratios yield different weight loss or metabolic outcomes depending on the individual's genotype.

If you have known genetic risks (like FTO variants), standard high-carb or low-fat diets might not be optimal. Consider discussing with a professional whether a high-protein or specific fat-modified diet aligns with your genetic profile for better weight management.

Dietary interventions targeting gut microbiota composition (e.g., prebiotics, probiotics, or specific fiber types) can improve glucose homeostasis and insulin sensitivity in obese individuals, particularly by modulating the Firmicutes/Bacteroidetes ratio and reducing pro-inflammatory bacterial species.

Focus on dietary fibers and fermented foods to support a healthy gut microbiome. This may help improve insulin sensitivity and reduce inflammation, which are key drivers of obesity and metabolic syndrome.

Regular consumption of low/no calorie sweetened beverages (LNCSB) is a common and effective strategy for weight loss maintenance, as it helps individuals control total calorie intake without increasing hunger or subsequent food intake.

If you are trying to maintain weight loss, drinking low/no calorie sweetened beverages (like diet soda, diet coffee, or unsweetened tea) is a valid and common strategy. It helps you reduce total calories without making you hungrier. Focus on replacing sugary drinks with these options or water, as successful maintainers do.

Long-term weight loss maintenance using a low-carbohydrate diet is possible and results in no greater weight regain compared to other dietary approaches over a 3-year period.

If you have successfully lost weight using a low-carbohydrate approach, you can likely maintain that loss long-term without needing to drastically increase your physical activity or dietary restraint compared to others. The key is adherence to your chosen dietary pattern, regardless of whether it involves higher fat intake or lower exercise volumes, as long as you maintain your weight loss.

A slow digestion-oriented dietary strategy that delivers nutrients to the distal small intestine and colon sustains GLP-1 secretion, thereby improving glucose homeostasis.

To improve blood sugar control, choose foods that digest slowly. This includes whole grains, viscous fibers, and foods with natural enzyme inhibitors. The goal is to get nutrients to your lower intestine to trigger sustained GLP-1 release, which helps manage glucose levels over a longer period.

Omega-3 polyunsaturated fatty acids (n-3 PUFA), specifically EPA and DHA, can reduce body fat mass and abdominal adiposity, but may not significantly reduce total body weight in overweight or obese individuals when used as a supplement alone.

Omega-3 supplements (EPA/DHA) may help reduce body fat, especially abdominal fat, but are unlikely to cause significant total weight loss on their own. They are most effective when combined with calorie restriction and exercise.

High consumption of ultra-processed foods (UPFs) is associated with specific alterations in gut microbiota composition, including decreased Lachnospira and Ruminococcus species and increased Prevotella species, though effects on overall microbial diversity (alpha/beta) are inconsistent across studies.

If you consume a high amount of ultra-processed foods, you may see a shift in your gut bacteria, specifically a decrease in beneficial fiber-fermenting types like Lachnospira and an increase in Prevotella. While overall diversity might not change significantly in all cases, these specific shifts are linked to higher UPF intake. To support a healthier microbiome, consider reducing UPF intake and increasing fiber-rich whole foods.

High consumption of ultra-processed foods is associated with negative health outcomes including increased depression/anxiety, higher BMI/weight, and decreased HDL cholesterol, particularly in men consuming >5 servings/day.

Eating more than 5 servings of ultra-processed foods daily is linked to higher body weight, worse cholesterol (lower HDL in men), and higher rates of depression and anxiety in women. Reducing UPF intake below this threshold may help improve these health markers.

Highly processed, palatable, and cheap foods (high in sugar, fat, salt, and flavor additives) trigger overconsumption of calories by shifting eating behaviors from home cooking to snacking and large-portion meals.

Prioritize whole, unprocessed foods over highly processed options. Be aware that processed foods with added sugar, fat, and salt are engineered to promote overconsumption, making portion control difficult.

The reduction in occupational physical activity, rather than a lack of formal exercise, is a major contributor to the obesity epidemic, creating a zone of low energy expenditure where intake becomes uncoupled from expenditure.

Incorporate movement into your workday. If your job is sedentary, try to stand, walk, or move frequently during the day, as this has a larger impact on daily energy expenditure than formal exercise alone.

In men with obesity and metabolic syndrome, a 12-week weight reduction program significantly decreases the postprandial brain-derived neurotrophic factor (BDNF) increment, with a 6% weight loss threshold predicting a negative BDNF index (postprandial levels lower than fasting).

For men with obesity and metabolic syndrome, losing just 6% of body weight over 12 weeks via a moderate caloric deficit and exercise can significantly normalize the body's post-meal hormonal response (BDNF). This suggests that even modest weight loss can reverse specific metabolic dysregulations related to energy homeostasis, potentially reducing cardiovascular risks associated with high postprandial BDNF.

High intake of dietary fiber, particularly soluble and cereal fiber, improves glycemic control, reduces HbA1c, and lowers the risk of type 2 diabetes.

Increase your daily intake of dietary fiber by eating more fruits, vegetables, legumes, nuts, and whole grains. This can significantly improve blood sugar control, lower HbA1c, and reduce the risk of type 2 diabetes.

GLP-1 agonists (specifically liraglutide and exenatide) induce significant weight loss in patients with antipsychotic-induced weight gain (AIWG) without worsening psychiatric symptoms.

For patients gaining weight from antipsychotics, GLP-1 agonists like liraglutide or exenatide are effective tools for weight loss. Liraglutide shows stronger results (-4.7 kg) than exenatide (-2.5 kg). These drugs do not worsen mental health symptoms, making them safe adjuncts to antipsychotic therapy. Side effects like nausea are common but usually manageable.

Single-joint (SJ) exercises produce greater hypertrophy of specific limb muscles (e.g., hamstrings, rectus femoris, long head of triceps) than multi-joint (MJ) exercises, necessitating a fractional set-count (less than 1:1) for MJ exercises when prescribing volume for those specific muscles.

When programming for specific muscles, recognize that multi-joint exercises (like squats or bench press) may not fully fatigue all target muscles (like hamstrings or triceps long head). If hypertrophy of these specific muscles is a priority, consider adding single-joint isolation exercises or counting the multi-joint sets as less than one full set for that specific muscle. For general strength or overall mass, the standard 1:1 count is likely sufficient.

Current longitudinal evidence is insufficient to definitively prescribe fractional set counts for MJ exercises; therefore, practitioners should default to a 1:1 ratio and use individual expertise to adjust.

Stick to counting every set as one set for now. If you notice a specific muscle (like hamstrings or triceps) isn't growing despite heavy multi-joint work, consider adding single-joint exercises for that muscle. Do not try to mathematically fractionate every set in your program.

Adherence to a Mediterranean diet pattern is associated with lower risk of cardiovascular disease mortality and combined vascular events in racial/ethnic minority populations, including African Americans, Hispanics, and Japanese Americans, though effect sizes and statistical significance vary by specific ethnic subgroup and study design.

For racial/ethnic minority populations, adopting a Mediterranean-style dietary pattern is associated with reduced cardiovascular mortality. This does not require strict adherence to traditional Mediterranean foods; instead, focus on increasing intake of vegetables, fruits, legumes, nuts, and healthy fats (like corn oil or olive oil) while limiting red and processed meats. Culturally adapted versions of the diet have shown similar benefits to white populations in several US studies.

Adherence to a Mediterranean diet is associated with lower risk of type 2 diabetes in white populations, but this association is not consistently observed in non-white ethnic groups (Native Hawaiians, Japanese Americans) when using standard MedDiet scores.

While the Mediterranean diet is beneficial for preventing type 2 diabetes in white populations, its effectiveness may vary in other ethnic groups. For Native Hawaiians and Japanese Americans, other dietary patterns (like DASH or alternate Healthy Eating Index) might be more predictive of diabetes risk. Focus on overall diet quality and culturally appropriate healthy foods rather than strict adherence to a specific named diet.